Published in J Infect Dis on July 01, 1993
Variable number of tandem repeats in clinical strains of Haemophilus influenzae. Infect Immun (1997) 2.92
Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev (2007) 1.74
Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol (2004) 1.39
Outbreak of amoxicillin-resistant Haemophilus influenzae type b: variable number of tandem repeats as novel molecular markers. J Clin Microbiol (1997) 1.35
Campylobacter enteritis. Clin Gastroenterol (1979) 18.67
Related vibrio in stools. J Pediatr (1973) 12.85
Acute enteritis due to related vibrio: first positive stool cultures. J Infect Dis (1972) 9.82
Campylobacter enteritis in Brussels. Lancet (1978) 6.37
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42
Enteritis due to "related vibrio" in children. Am J Dis Child (1973) 5.04
Identification and classification of bacterial plasmids. Microbiol Rev (1988) 4.16
Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol (1992) 4.13
Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother (1982) 3.52
Campylobacter enteritis in Central Africa. Lancet (1978) 3.20
Campylobacter serotyping a epidemiology. Lancet (1981) 3.18
Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet (1985) 2.84
Letter: Related vibrios in Africa. Lancet (1973) 2.76
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60
Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother (1974) 2.41
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol (1986) 2.25
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
Positive-selection vectors using the F plasmid ccdB killer gene. Gene (1994) 2.12
Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol (1992) 2.11
Campylobacter upsaliensis enteritis associated with canine infections. Lancet (1991) 2.05
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03
Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol (1994) 2.02
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
Leishmaniasis acquired in Belgium. Lancet (1991) 1.93
Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91
Routine culture of Giardia lamblia trophozoites from human duodenal aspirates. Lancet (1984) 1.86
Community-acquired bacteremia among hospitalized children in rural central Africa. Int J Infect Dis (2001) 1.76
Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol (1995) 1.72
Electron microscopical studies on the localisation of the different components of cell walls of gram-negative bacteria. Folia Microbiol (Praha) (1967) 1.68
The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J Mol Biol (1993) 1.68
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol (2001) 1.60
The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology (1975) 1.59
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
ATP-dependent degradation of CcdA by Lon protease. Effects of secondary structure and heterologous subunit interactions. J Biol Chem (1996) 1.55
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52
Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med (1988) 1.45
Interaction between the RP4 coupling protein TraG and the pBHR1 mobilization protein Mob. Mol Microbiol (2000) 1.40
Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol (1992) 1.38
Neutralization of poliovirus by antibody-mediated polymerization. Virology (1983) 1.38
[Digestive origin of Campylobacter septicemias]. Nouv Presse Med (1977) 1.37
Enteropathogenic agents in children with diarrhoea in rural Zaire. Lancet (1983) 1.35
The ratio between CcdA and CcdB modulates the transcriptional repression of the ccd poison-antidote system. Mol Microbiol (2001) 1.35
Crystal structure of CcdB, a topoisomerase poison from E. coli. J Mol Biol (1999) 1.35
High pleiotropy of streptomycin mutations in Escherichia coli. Biochem Biophys Res Commun (1964) 1.34
Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry (1997) 1.33
Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea? Lancet (1990) 1.32
Failure of live, attenuated oral rotavirus vaccine. Lancet (1986) 1.30
Mini-F encoded proteins: identification of a new 10.5 kilodalton species. EMBO J (1983) 1.29
Campylobacter pyloridis in children. Lancet (1986) 1.28
Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod (1997) 1.24
Humoral antibody response to bovine leukemia virus infection in cattle and sheep. Cancer Res (1979) 1.24
Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23
Interactions of CcdB with DNA gyrase. Inactivation of Gyra, poisoning of the gyrase-DNA complex, and the antidote action of CcdA. J Biol Chem (1999) 1.23
Campylobacter jejuni post-transfusional septicaemia. Lancet (1979) 1.20
Isolation and location on the R27 map of two replicons and an incompatibility determinant specific for IncHI1 plasmids. J Bacteriol (1993) 1.20
Stomatitis with septicemia due to Moraxella osloensis. J Pediatr (1974) 1.20
Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol (1998) 1.19
Ham22, a mini-F mutation which is lethal to host cell and promotes recA-dependent induction of lambdoid prophage. EMBO J (1983) 1.19
Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimens. J Clin Microbiol (1989) 1.18
Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.16
Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol (1988) 1.15
The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol Gen Genet (1994) 1.13
The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription. J Mol Biol (1997) 1.12
F plasmid CcdB killer protein: ccdB gene mutants coding for non-cytotoxic proteins which retain their regulatory functions. Mol Microbiol (1995) 1.12
Bovine leukemia virus involvement in enzootic bovine leukosis. Adv Cancer Res (1978) 1.12
Cloning and characterization of the Inc A/C plasmid RA1 replicon. J Bacteriol (1994) 1.09
New selective medium for isolation of Campylobacter jejuni from faecal specimens. Lancet (1983) 1.08
Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol (2001) 1.08
Paediatric campylobacter diarrhoea from household exposure to live chickens in Lima, Peru. Bull World Health Organ (1988) 1.08
Prevalence of four enterotoxin (STaP, STaH, STb, and LT) and four adhesin subunit (K99, K88, 987P, and F41) genes among Escherichia coli isolates from cattle. Am J Vet Res (1990) 1.07
Macromolecular structure of lipopolysaccharides from gram-negative bacteria. Eur J Biochem (1973) 1.07
Campylobacter enteritis. Acta Paediatr Belg (1979) 1.06
Disk sensitivity testing for Campylobacter jejuni. Eur J Clin Microbiol (1984) 1.06
Evaluation of a new method for routine in vitro cultivation of Giardia lamblia from human duodenal fluid. J Clin Microbiol (1985) 1.06
Comparison of biotyping, ribotyping, and pulsed-field gel electrophoresis for investigation of a common-source outbreak of Burkholderia pickettii bacteremia. J Clin Microbiol (1997) 1.06
Evidence of poxvirus in dusky dolphin (Lagenorhynchus obscurus) and Burmeister's porpoise (Phocoena spinipinnis) from coastal Peru. J Wildl Dis (1993) 1.06
Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr Infect Dis J (2001) 1.06
Complement-fixation antibodies to adenovirus-associated viruses, cytomegaloviruses and herpes simplex viruses in patients with tumors and in control individuals. Am J Epidemiol (1971) 1.06
Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol (1987) 1.05
In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrob Agents Chemother (1985) 1.05
Yersinia pseudotuberculosis septicaemia in thalassaemia major. Lancet (1984) 1.04
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother (1983) 1.04
A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia (2009) 1.03
Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1992) 1.03
In-vitro activity of new cephalosporin (HR 756) and cefazolin. Lancet (1978) 1.03
[Self-medication with antibiotics obtained from private pharmacies in Abidjan, Ivory Coast]. Med Mal Infect (2009) 1.03
Detection of complement-dependent lytic antibodies in sera from bovine leukemia virus-infected animals. Ann Rech Vet (1978) 1.02
Control of development in temperate bacteriophages. V. Sequential activation of the viral functions. Mol Gen Genet (1973) 1.02
Molecular analysis of the replication elements of the broad-host-range RepA/C replicon. Plasmid (1996) 1.02